Horm Metab Res 2016; 48(01): 62-69
DOI: 10.1055/s-0035-1559722
Endocrine Research
© Georg Thieme Verlag KG Stuttgart · New York

Insulin and Leptin Signaling in Placenta from Gestational Diabetic Subjects

A. Pérez-Pérez
1   Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, Seville, Spain
,
P. Guadix
2   Obstetrics and Gynecology Service, Virgen Macarena University Hospital, Seville, Spain
,
J. Maymó
3   Department of Biological Chemistry, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
,
J. L. Dueñas
2   Obstetrics and Gynecology Service, Virgen Macarena University Hospital, Seville, Spain
,
C. Varone
3   Department of Biological Chemistry, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Buenos Aires, Argentina
,
M. Fernández-Sánchez
4   IVI Seville, Seville, Spain
,
V. Sánchez-Margalet
1   Department of Medical Biochemistry and Molecular Biology, School of Medicine, Virgen Macarena University Hospital, Seville, Spain
› Author Affiliations
Further Information

Publication History

received 17 November 2014

accepted 28 July 2015

Publication Date:
19 November 2015 (online)

Abstract

Insulin and leptin receptors are known to share signaling pathways, such as JAK2/STAT-3 (Janus kinase2/signal transduction and activator of transcription3), MAPK (Mitogen activated protein kinase), and PI3K (phosphoinositide 3-kinase). Both positive and negative cross-talk have been previously found in different cellular systems. Gestational diabetes (GDM) is a pathophysiological state with high circulating levels of both insulin and leptin. We have previously found that these 3 signaling pathways are activated in placenta from GDM patients to promote translation, involving the activation of leptin receptor. Now, we have tested the hypothesis that both leptin and insulin receptors might contribute to this activation in a positive way that may become negative when the system is overactivated. We studied the activation of leptin and insulin receptors in placenta from GDM and healthy pregnancies. We have also performed in vitro studies with insulin and leptin stimulation of trophoblast explants from healthy placenta. We have found that both leptin and insulin receptors are activated in placenta from GDM. In vitro stimulation of trophoblast explants with both leptin and insulin at submaximal doses (0.1 nM) potentiated the activation of signaling, whereas preincubation with maximal concentrations of insulin (10 nM) and further stimulation with leptin showed negative effect. Trophoblastic explants from GDM placenta, which presented high signaling levels, had a negative signaling effect when further incubated in vitro with leptin. In conclusion, insulin and leptin receptors have positive effects on signaling, contributing to high signaling levels in GDM placenta, but insulin and leptin have negative effects upon overstimulation.

 
  • References

  • 1 Masuzaki H, Ogawa Y, Sagawa N, Hosoda K, Matsumoto T, Mise H, Nishimura H, Yoshimasa Y, Tanaka I, Mori T, Nakao K. Nonadipose tissue production of leptin: leptin as a novel placenta-derived hormone in humans. Nat Med 1997; 3: 1029-1033
  • 2 Senaris R, Garcia-Caballero T, Casabiell X, Gallego R, Castro R, Considine RV, Dieguez C, Casanueva FF. Synthesis of leptin in human placenta. Endocrinology 1997; 138: 4501-4504
  • 3 Magarinos MP, Sanchez-Margalet V, Kotler M, Calvo JC, Varone CL. Leptin promotes cell proliferation and survival of trophoblastic cells. Biol Reprod 2007; 76: 203-210
  • 4 Perez-Perez A, Maymo J, Duenas JL, Goberna R, Calvo JC, Varone C, Sanchez-Margalet V. Leptin prevents apoptosis of trophoblastic cells by activation of MAPK pathway. Arch Biochem Biophys 2008; 477: 390-395
  • 5 Perez-Perez A, Maymo J, Gambino Y, Duenas JL, Goberna R, Varone C, Sanchez-Margalet V. Leptin stimulates protein synthesis-activating translation machinery in human trophoblastic cells. Biol Reprod 2009; 81: 826-832
  • 6 Perez-Perez A, Gambino Y, Maymo J, Goberna R, Fabiani F, Varone C, Sanchez-Margalet V. MAPK and PI3K activities are required for leptin stimulation of protein synthesis in human trophoblastic cells. Biochem Biophys Res Commun 2010; 396: 956-960
  • 7 Bajoria R, Sooranna SR, Ward BS, Chatterjee R. Prospective function of placental leptin at maternal-fetal interface. 23 (ed.). 2002; 103-115
  • 8 Perez-Perez A, Maymo JL, Gambino YP, Guadix P, Duenas JL, Varone CL, Sanchez-Margalet V. Activated translation signaling in placenta from pregnant women with gestational diabetes mellitus: possible role of leptin. Horm Metab Res 2013; 45: 436-442
  • 9 Sagawa N, Yura S, Itoh H, Mise H, Kakui K, Korita D, Takemura M, Nuamah MA, Ogawa Y, Masuzaki H, Nakao K, Fujii S. Role of leptin in pregnancy–a review. Placenta 2002; 23 Suppl A S80-S86
  • 10 Sooranna SR, Ward S, Bajoria R. Fetal leptin influences birth weight in twins with discordant growth. Pediatr Res 2001; 49: 667-672
  • 11 Desoye G, Hauguel-De MS. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care 2007; 30 (Suppl. 02) S120-S126
  • 12 Kuruvilla AG, D’Souza SW, Glazier JD, Mahendran D, Maresh MJ, Sibley CP. Altered activity of the system A amino acid transporter in microvillous membrane vesicles from placentas of macrosomic babies born to diabetic women. J Clin Invest 1994; 94: 689-695
  • 13 Fowden AL, Forhead AJ. Endocrine regulation of feto-placental growth. Horm Res 2009; 72: 257-265
  • 14 Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J, Hauguel-De MS. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998; 47: 847-850
  • 15 Perez-Perez A, Maymo J, Gambino Y, Guadix P, Duenas JL, Varone C, Sanchez-Margalet V. Insulin Enhances Leptin Expression in Human Trophoblastic Cells. Biol Reprod 2013; 89: 20 DOI: 10.1095/biolreprod.113.109348.
  • 16 Barbour LA, McCurdy CE, Hernandez TL, Kirwan JP, Catalano PM, Friedman JE. Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 2007; 30 (Suppl. 02) S112-S119
  • 17 Lin CY, Higginbotham DA, Judd RL, White BD. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab 2002; 282: E1084-E1091
  • 18 Giorgetti-Peraldi S, Peyrade F, Baron V, Van OE. Involvement of Janus kinases in the insulin signaling pathway. Eur J Biochem 1995; 234: 656-660
  • 19 Desoye G, Hofmann HH, Weiss PA. Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects. Diabetologia 1992; 35: 45-55
  • 20 Benomar Y, Roy AF, Aubourg A, Djiane J, Taouis M. Cross down-regulation of leptin and insulin receptor expression and signalling in a human neuronal cell line. Biochem J 2005; 388: 929-939
  • 21 Berti L, Kellerer M, Capp E, Haring HU. Leptin stimulates glucose transport and glycogen synthesis in C2C12 myotubes: evidence for a P13-kinase mediated effect. Diabetologia 1997; 40: 606-609
  • 22 Sweeney G, Keen J, Somwar R, Konrad D, Garg R, Klip A. High leptin levels acutely inhibit insulin-stimulated glucose uptake without affecting glucose transporter 4 translocation in l6 rat skeletal muscle cells. Endocrinology 2001; 142: 4806-4812
  • 23 Szanto I, Kahn CR. Selective interaction between leptin and insulin signaling pathways in a hepatic cell line. Proc Natl Acad Sci USA 2000; 97: 2355-2360
  • 24 Baskin DG, Figlewicz LD, Seeley RJ, Woods SC, Porte Jr D, Schwartz MW. Insulin and leptin: dual adiposity signals to the brain for the regulation of food intake and body weight. Brain Res 1999; 848: 114-123